Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | LIPE | Q05469 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3893963 | 0.85 | TSHR (0.48) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL3080694 | 0.79 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL17333443 | 0.79 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL2025672 | 0.79 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL6987582 | 0.79 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1CA1 | |
| Boric Acid SCHEMBL28556682 | 0.77 | TSHR (0.50) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL4255626 | 0.75 | TSHR (0.54) | TSHRIDO1AGXTLMNAL3MBTL1 | |
| SCHEMBL6132101 | 0.75 | IDO1 (0.50) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL933492 | 0.75 | LIPE (0.50) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL22006983 | 0.75 | IDO1 (0.50) | TSHRIDO1AGXTALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120137571-A | Biological safety type silane modified MS sealant for container | 安徽欣苗新材料科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-116284784-B | Preparation method of recyclable orthogonal dynamic covalent fluorescent polymer material | 华东理工大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120025356-A | Method for synthesizing acyl trifluoro borate compound through benzyl borate compound and application thereof | 华东师范大学 | 2025-05-23 | — | — | CN | claimed |
| CN-119775293-A | Chiral benzyl borate compound and preparation method of chiral hydroxyl compound thereof | 湖北工程学院 | 2025-04-08 | — | — | CN | claimed |
| US-12262626-B2 | Thermosetting liquid composition for encapsulant in organic light-emitting device | INNOX ADVANCED MATERIALS CO., LTD. (KR) | 2025-03-25 | — | — | US | claimed |
| CN-117777171-A | Preparation method and application of chiral benzyl borate | 浙江理工大学嵊州创新研究院有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-113735889-B | Process method for synthesizing cyclopropylboric acid | 大连双硼医药化工有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116284784-A | Preparation method of recyclable orthogonal dynamic covalent fluorescent polymer material | 华东理工大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116253755-A | Synthesis method of diaryl borate compound | 湖南大学 | 2023-06-13 | — | — | CN | claimed |
| CN-113929712-B | Simple preparation method of benzyl borate compound | 山东大学 | 2022-11-18 | — | — | CN | claimed |
| CN-110790661-A | Method for converting benzyl borate compounds into phenylacetic acid and derivatives thereof by using carbon dioxide | 北京大学 | 2020-02-14 | — | — | CN | claimed |
| CN-109994777-A | Electrolyte solution and secondary battery | 宁德时代新能源科技股份有限公司 | 2019-07-09 | — | — | CN | claimed |
| US-20180244700-A1 | METHODS OF TREATING A FATTY ACID AMIDE HYDROLASE-MEDIATED CONDITION | INFINITY PHARMACEUTICALS, INC. | 2018-08-30 | — | — | US | claimed |
| US-20150239912-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | INFINITY PHARMACEUTICALS, INC. | 2015-08-27 | — | — | US | claimed |
| EP-2531511-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | Infinity Pharmaceuticals, Inc. (US) | 2012-12-12 | — | — | EP | claimed |
| US-20110201574-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | INFINITY PHARMACEUTICALS, INC. | 2011-08-18 | — | — | US | claimed |
| WO-2011097233-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | INFINITY PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | WO | claimed |
| CN-100374533-C | lubricant composition for sewing machine | NIPPON STEEL CHEMICAL CO (JP) | 2008-03-12 | — | — | CN | claimed |
| EP-0942028-B1 | Epoxy resin composition | AJINOMOTO KK (JP) | 2004-11-24 | — | — | EP | claimed |
| US-6232426-B1 | BLEND CONTAINING A THIOL, COMPOUND, LATENT CURING AGENT AND BORATE EATER | AJINOMOTO CO., INC. (JP) | 2001-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201574-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | FAAH, FAAH2, FASN | TSHR 2597/4885IDO1 1106/4885AGXT 210/4885 |
| US-20180244700-A1 | METHODS OF TREATING A FATTY ACID AMIDE HYDROLASE-MEDIATED CONDITION | FAAH, FAAH2, FASN | TSHR 2480/4885IDO1 780/4885AGXT 190/4885 |
| US-20150239912-A1 | FATTY ACID AMIDE HYDROLASE INHIBITORS | FAAH, FAAH2, FASN | TSHR 2597/4885IDO1 1106/4885AGXT 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.